The latest learning and CPD content on adherence, compliance and concordance. Under ‘Other resources’ you will find all our other content related to adherence, compliance and concordance.
CPD and Learning
This article outlines how community pharmacists can play an important role in medicines adherence, including examples of how to reinforce treatment.
Smoking cessation services: how nicotine replacement therapy and counselling through pharmacy can support adherence and quittingSubscription
Smoking is the primary cause of preventable ill health and death in the UK. Pharmacists and pharmacy teams are well placed to provide stop-smoking services, which are cost-effective interventions to help people give up smoking.
Providing medicines adherence support to areas of high deprivation in England: community pharmacists’ experienceSubscription
Semi-structured interviews assessing pharmacists’ experiences of providing interventions, products and services that support medicine adherence.
Regular consultations with pharmacists lead to improved medicine adherence in people with chronic heart failure, research results show.
A post-myocardial infarction medicines optimisation clinic, led primarily by a pharmacist with support from a cardiologist, has resulted in improved medicines adherence and guideline concordance, study results published in Open Heart show.
Millions of multicompartment compliance aids (MCAs) are handed out by pharmacists each year, but evidence for their benefits is hard to find. Few patients are assessed before being given an MCA and concerns are building over potential errors and harms.
High adherence to intensive lipid-lowering therapy provides the greatest risk reduction for cardiovascular events, a study in JAMA Network Open has shown.
A substantial proportion of older people who begin taking statins do not take them as intended, according to an Australian study published in the British Journal of Clinical Pharmacology.
Medicine reminder apps can improve self-reported adherence to cardiovascular medicines, according to findings from a randomised clinical trial presented at the European Society of Cardiology Congress.
Some 16% of premenopausal women with early-onset breast cancer fail to adequately adhere to tamoxifen, increasing their risk of recurrence and reduced survival.